AI Strategy Lead
Pfizer
Dr. Mohamed Shahin is a Senior Director, AI Strategy Lead at Pfizer with over a decade of experience in clinical pharmacology and translational research. Throughout his career, he has consistently driven innovation at the intersection of clinical pharmacology, data science and drug development, and supported the implementation of MIDD strategies for improving trial efficiency and budget savings. He co-authored over 100 peer-reviewed publications and conference proceedings and delivered more than 30 scientific presentations at national and international meetings. He currently serves as an Associate Editor for the Clinical and Translational Science journal and an Editorial Board member for the Clinical Pharmacology and Therapeutics journal. He is also a dedicated mentor and an active contributor to professional societies, including ASCPT, PGRN, and the IQ Consortium.
Disclosure information not submitted.
Pharmacometrics Phisticuffs 4* – Is AIML or QSP saving the day for Pharmacometrics?
Saturday, October 18, 2025
3:00 PM - 3:30 PM MDT